In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain welcome Dr. Martina Murphy, an Associate Professor of Medicine and Senior Associate Dean of Graduate Medical Education at the University of Florida, to discuss the current landscape of ovarian cancer.

Join us as we dive into the critical aspects of diagnosing and managing ovarian cancer, including:

•⁠  ⁠The importance of surgical staging and primary debulking surgery

•⁠  ⁠The role of genetic testing, including BRCA and NGS, in treatment planning

•⁠  ⁠Adjuvant therapy options, focusing on platinum-based chemotherapy and the use of Bevacizumab

•⁠  ⁠Insights into PARP inhibitors and their application in BRCA-positive and wild-type patients

•⁠  ⁠Navigating treatment options for relapsed and refractory ovarian cancer, including the use of antibody-drug conjugates like Mirvetuximab and Trastuzumab Deruxtecan (TDXd).

Dr. Murphy shares her expertise on the latest advancements in ovarian cancer treatment, the significance of genetic testing, and the management of side effects associated with various therapies.

Tune in for a comprehensive overview of the standard of care for ovarian cancer and the evolving treatment landscape. Don't forget to check out our other episodes for more discussions on practice-changing data and current treatment options in oncology!

Subscribe to the Oncology Brothers podcast for more insights and updates in the field of oncology!

Website: http://www.oncbrothers.com/

X/Twitter: https://twitter.com/oncbrothers

Contact us at info@oncbrothers.com